Anti-HER2 Single Domain Antibody 2Rs15d Labeled with 18F Using a Residualizing Label: Preliminary Evaluation

被引：0
|
作者：
Vaidyanathan, G. V. [1 ]
Zhou, Z. [1 ]
McDougald, D. [1 ]
Lahoutte, T. [2 ]
Zalutsky, M. R. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Brussels, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP594
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [1] Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation
    Zhou, Zhengyuan
    Vaidyanathan, Ganesan
    McDougald, Darryl
    Kang, Choong Mo
    Balyasnikova, Irina
    Devoogdt, Nick
    Ta, Angeline N.
    McNaughton, Brian R.
    Zalutsky, Michael R.
    MOLECULAR IMAGING AND BIOLOGY, 2017, 19 (06) : 867 - 877
  • [2] Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation
    Zhengyuan Zhou
    Ganesan Vaidyanathan
    Darryl McDougald
    Choong Mo Kang
    Irina Balyasnikova
    Nick Devoogdt
    Angeline N. Ta
    Brian R. McNaughton
    Michael R. Zalutsky
    Molecular Imaging and Biology, 2017, 19 : 867 - 877
  • [3] An Anti-HER2 Nanobody Labeled with 18F Using a Residualizing Label for Assessing HER2 Status
    Vaidyanathan, G.
    McDougald, D.
    Choi, J.
    Koumarianou, E.
    Pruszynski, M.
    Osada, T.
    Lyerly, H.
    Lahoutte, T.
    Zalutsky, M. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S102 - S102
  • [4] Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
    Zhou, Zhengyuan
    Meshaw, Rebecca
    Zalutsky, Michael R.
    Vaidyanathan, Ganesan
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (11) : 1624 - 1630
  • [5] Labeling an anti-HER2 VHH with 18F using a residualizing prosthetic group via strain-promoted click reaction: preliminary evaluation
    Zhou, Zhengyuan
    Devoogdt, Nick
    Zalutsky, Michael
    Vaidyanathan, Ganesan
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [6] 225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy - an in vitro and in vivo evaluation
    Rodak, Magdalena
    Dekempeneer, Yana
    Wojewodzka, Maria
    Lahoutte, Tony
    Bruchertseifer, Frank
    Morgenstern, Alfred
    D'Huyvetter, Matthias
    Pruszynski, Marek
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S33 - S33
  • [7] Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation
    Choi, Jaeyeon
    Vaidyanathan, Ganesan
    Koumarianou, Eftychia
    Kang, Choong Mo
    Zalutsky, Michael R.
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 56 : 10 - 20
  • [8] Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent
    Feng, Yutian
    Zhou, Zhengyuan
    McDougald, Darryl
    Meshaw, Rebecca L.
    Vaidyanathan, Ganesan
    Zalutsky, Michael R.
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 92 : 171 - 183
  • [9] MicroPET imaging of HER2+tumors using F-18-labeled anti-HER2 diabody
    Sirk, Shannon
    Olma, Sebastian
    Shen, Clifton
    Lepin, Eric
    Liu, Kan
    Olafsen, Tove
    Wu, Anna
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [10] A 177Lu-labeled anti-HER2 dual variable domain antibody
    MacPherson, Douglas
    Hwang, Dobeen
    Sarrett, Samantha
    Rodriguez, Cindy
    Keinaenen, Outi
    Rader, Christoph
    Zeglis, Brian
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S9 - S9
12345